APO Research
Talk to an analyst

APO RESEARCH · REPORT

Heparin Sodium Injection

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Heparin Sodium Injection Industry Growth and Trends Forecast to 2032

22 December 2025112 pages

Choose your research edition.

Industry ResearchHeparin Sodium Injection Industry Research Report 2026132 pages · $2,950 USDIndustry Growth & TrendsGlobal Heparin Sodium Injection Industry Growth and Trends Forecast to 2032112 pages · $3,450 USDMarket StructureGlobal Heparin Sodium Injection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Heparin Sodium Injection Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Heparin Sodium Injection Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Heparin Sodium Injection market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Heparin Sodium Injection is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Heparin Sodium Injection is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Heparin Sodium Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Heparin Sodium Injection include Sichuan Deebio, Shenzhen Hepalink, Nanjing King-friend, Pfizer, Changzhou Qianhong Bio-pharma, Baxter, Yino Pharma Limited, Xinbai Pharmaceuticals and Pharma Action, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Heparin Sodium Injection market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Heparin Sodium Injection market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Heparin Sodium Injection market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Heparin Sodium Injection.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Heparin Sodium Injection market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Heparin Sodium Injection Market by Company

Sichuan Deebio

Shenzhen Hepalink

Nanjing King-friend

Pfizer

Changzhou Qianhong Bio-pharma

Baxter

Yino Pharma Limited

Xinbai Pharmaceuticals

Pharma Action

Opocrin

Dongying Tiandong Pharmaceutical

Dongcheng Biochemicals

Changshan Biochemical

Bioibérica

Aspen Oss

Heparin Sodium Injection Segment by Type

1, 000 USP Units / mL

5, 000 USP Units / mL

10, 000 USP Units / mL

Heparin Sodium Injection Segment by Application

Cardioversion of Atrial Fibrillation/Flutter

Complications of Pregnancy

Treatment of Venous Thromboembolism

Other

Heparin Sodium Injection Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Heparin Sodium Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Heparin Sodium Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Heparin Sodium Injection.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Heparin Sodium Injection manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Heparin Sodium Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of 1, 000 USP Units / mL Table 2. Major Company of 5, 000 USP Units / mL Table 3. Major Company of 10, 000 USP Units / mL Table 4. Global Heparin Sodium Injection Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Heparin Sodium Injection Sales by Type (2021-2026) & (k units) Table 6. Global Heparin Sodium Injection Sales Market Share in Volume by Type (2021-2026) Table 7. Global Heparin Sodium Injection Sales by Type (2021-2026) & (US$ Million) Table 8. Global Heparin Sodium Injection Sales Market Share in Value by Type (2021-2026) Table 9. Global Heparin Sodium Injection Price by Type (2021-2026) & (US$/unit) Table 10. Global Heparin Sodium Injection Sales by Type (2027-2032) & (k units) Table 11. Global Heparin Sodium Injection Sales Market Share in Volume by Type (2027-2032) Table 12. Global Heparin Sodium Injection Sales by Type (2027-2032) & (US$ Million) Table 13. Global Heparin Sodium Injection Sales Market Share in Value by Type (2027-2032) Table 14. Global Heparin Sodium Injection Price by Type (2027-2032) & (US$/unit) Table 15. North America Heparin Sodium Injection Sales by Type (2021-2026) & (k units) Table 16. North America Heparin Sodium Injection Sales by Type (2021-2026) & (US$ Million) Table 17. Europe Heparin Sodium Injection Sales by Type (2021-2026) & (k units) Table 18. Europe Heparin Sodium Injection Sales by Type (2021-2026) & (US$ Million) Table 19. Asia-Pacific Heparin Sodium Injection Sales by Type (2021-2026) & (k units) Table 20. Asia-Pacific Heparin Sodium Injection Sales by Type (2021-2026) & (US$ Million) Table 21. Latin America Heparin Sodium Injection Sales by Type (2021-2026) & (k units) Table 22. Latin America Heparin Sodium Injection Sales by Type (2021-2026) & (US$ Million) Table 23. Middle East and Africa Heparin Sodium Injection Sales by Type (2021-2026) & (k units) Table 24. Middle East and Africa Heparin Sodium Injection Sales by Type (2021-2026) & (US$ Million) Table 25. Heparin Sodium Injection Industry Trends Table 26. Heparin Sodium Injection Industry Drivers Table 27. Heparin Sodium Injection Industry Opportunities and Challenges Table 28. Heparin Sodium Injection Industry Restraints Table 29. Global Heparin Sodium Injection Sales Revenue by Company (US$ Million) & (2021-2026) Table 30. Global Heparin Sodium Injection Revenue Market Share by Company (2021-2026) Table 31. Global Heparin Sodium Injection Sales by Company (2021-2026) & (k units) Table 32. Global Heparin Sodium Injection Sales Share by Company (2021-2026) Table 33. Global Heparin Sodium Injection Market Price by Company (2021-2026) & (US$/unit) Table 34. Global Heparin Sodium Injection Industry Company Ranking, 2024 VS 2025 VS 2026 Table 35. Global Heparin Sodium Injection Major Company Production Sites and Headquarters Table 36. Global Heparin Sodium Injection Company, Product Type & Application Table 37. Global Heparin Sodium Injection Company Establishment Date Table 38. Global Company Market Concentration Ratio (CR5 and HHI) Table 39. Global Heparin Sodium Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global Heparin Sodium Injection Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 41. Global Heparin Sodium Injection Sales by Region (2021-2026) & (k units) Table 42. Global Heparin Sodium Injection Sales Market Share in Volume by Region (2021-2026) Table 43. Global Heparin Sodium Injection Sales by Region (2021-2026) & (US$ Million) Table 44. Global Heparin Sodium Injection Sales Market Share in Value by Region (2021-2026) Table 45. Global Heparin Sodium Injection Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 46. Global Heparin Sodium Injection Sales by Region (2027-2032) & (k units) Table 47. Global Heparin Sodium Injection Sales Market Share in Volume by Region (2027-2032) Table 48. Global Heparin Sodium Injection Sales by Region (2027-2032) & (US$ Million) Table 49. Global Heparin Sodium Injection Sales Market Share in Value by Region (2027-2032) Table 50. Global Heparin Sodium Injection Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2027-2032) Table 51. Global Heparin Sodium Injection Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Global Heparin Sodium Injection Sales by Application (2021-2026) & (k units) Table 53. Global Heparin Sodium Injection Sales Market Share in Volume by Application (2021-2026) Table 54. Global Heparin Sodium Injection Sales by Application (2021-2026) & (US$ Million) Table 55. Global Heparin Sodium Injection Sales Market Share in Value by Application (2021-2026) Table 56. Global Heparin Sodium Injection Price by Application (2021-2026) & (US$/unit) Table 57. Global Heparin Sodium Injection Sales by Application (2027-2032) & (k units) Table 58. Global Heparin Sodium Injection Sales Market Share in Volume by Application (2027-2032) Table 59. Global Heparin Sodium Injection Sales by Application (2027-2032) & (US$ Million) Table 60. Global Heparin Sodium Injection Sales Market Share in Value by Application (2027-2032) Table 61. Global Heparin Sodium Injection Price by Application (2027-2032) & (US$/unit) Table 62. North America Heparin Sodium Injection Sales by Application (2021-2026) & (k units) Table 63. North America Heparin Sodium Injection Sales by Application (2021-2026) & (US$ Million) Table 64. Europe Heparin Sodium Injection Sales by Application (2021-2026) & (k units) Table 65. Europe Heparin Sodium Injection Sales by Application (2021-2026) & (US$ Million) Table 66. Asia-Pacific Heparin Sodium Injection Sales by Application (2021-2026) & (k units) Table 67. Asia-Pacific Heparin Sodium Injection Sales by Application (2021-2026) & (US$ Million) Table 68. Latin America Heparin Sodium Injection Sales by Application (2021-2026) & (k units) Table 69. Latin America Heparin Sodium Injection Sales by Application (2021-2026) & (US$ Million) Table 70. Middle East and Africa Heparin Sodium Injection Sales by Application (2021-2026) & (k units) Table 71. Middle East and Africa Heparin Sodium Injection Sales by Application (2021-2026) & (US$ Million) Table 72. Sichuan Deebio Company Information Table 73. Sichuan Deebio Business Overview Table 74. Sichuan Deebio Heparin Sodium Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 75. Sichuan Deebio Heparin Sodium Injection Product Portfolio Table 76. Sichuan Deebio Recent Development Table 77. Shenzhen Hepalink Company Information Table 78. Shenzhen Hepalink Business Overview Table 79. Shenzhen Hepalink Heparin Sodium Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 80. Shenzhen Hepalink Heparin Sodium Injection Product Portfolio Table 81. Shenzhen Hepalink Recent Development Table 82. Nanjing King-friend Company Information Table 83. Nanjing King-friend Business Overview Table 84. Nanjing King-friend Heparin Sodium Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 85. Nanjing King-friend Heparin Sodium Injection Product Portfolio Table 86. Nanjing King-friend Recent Development Table 87. Pfizer Company Information Table 88. Pfizer Business Overview Table 89. Pfizer Heparin Sodium Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 90. Pfizer Heparin Sodium Injection Product Portfolio Table 91. Pfizer Recent Development Table 92. Changzhou Qianhong Bio-pharma Company Information Table 93. Changzhou Qianhong Bio-pharma Business Overview Table 94. Changzhou Qianhong Bio-pharma Heparin Sodium Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 95. Changzhou Qianhong Bio-pharma Heparin Sodium Injection Product Portfolio Table 96. Changzhou Qianhong Bio-pharma Recent Development Table 97. Baxter Company Information Table 98. Baxter Business Overview Table 99. Baxter Heparin Sodium Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 100. Baxter Heparin Sodium Injection Product Portfolio Table 101. Baxter Recent Development Table 102. Yino Pharma Limited Company Information Table 103. Yino Pharma Limited Business Overview Table 104. Yino Pharma Limited Heparin Sodium Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 105. Yino Pharma Limited Heparin Sodium Injection Product Portfolio Table 106. Yino Pharma Limited Recent Development Table 107. Xinbai Pharmaceuticals Company Information Table 108. Xinbai Pharmaceuticals Business Overview Table 109. Xinbai Pharmaceuticals Heparin Sodium Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 110. Xinbai Pharmaceuticals Heparin Sodium Injection Product Portfolio Table 111. Xinbai Pharmaceuticals Recent Development Table 112. Pharma Action Company Information Table 113. Pharma Action Business Overview Table 114. Pharma Action Heparin Sodium Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 115. Pharma Action Heparin Sodium Injection Product Portfolio Table 116. Pharma Action Recent Development Table 117. Opocrin Company Information Table 118. Opocrin Business Overview Table 119. Opocrin Heparin Sodium Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 120. Opocrin Heparin Sodium Injection Product Portfolio Table 121. Opocrin Recent Development Table 122. Dongying Tiandong Pharmaceutical Company Information Table 123. Dongying Tiandong Pharmaceutical Business Overview Table 124. Dongying Tiandong Pharmaceutical Heparin Sodium Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 125. Dongying Tiandong Pharmaceutical Heparin Sodium Injection Product Portfolio Table 126. Dongying Tiandong Pharmaceutical Recent Development Table 127. Dongcheng Biochemicals Company Information Table 128. Dongcheng Biochemicals Business Overview Table 129. Dongcheng Biochemicals Heparin Sodium Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 130. Dongcheng Biochemicals Heparin Sodium Injection Product Portfolio Table 131. Dongcheng Biochemicals Recent Development Table 132. Changshan Biochemical Company Information Table 133. Changshan Biochemical Business Overview Table 134. Changshan Biochemical Heparin Sodium Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 135. Changshan Biochemical Heparin Sodium Injection Product Portfolio Table 136. Changshan Biochemical Recent Development Table 137. Bioibérica Company Information Table 138. Bioibérica Business Overview Table 139. Bioibérica Heparin Sodium Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 140. Bioibérica Heparin Sodium Injection Product Portfolio Table 141. Bioibérica Recent Development Table 142. Aspen Oss Company Information Table 143. Aspen Oss Business Overview Table 144. Aspen Oss Heparin Sodium Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 145. Aspen Oss Heparin Sodium Injection Product Portfolio Table 146. Aspen Oss Recent Development Table 147. North America Heparin Sodium Injection Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 148. North America Heparin Sodium Injection Sales by Country (2021-2026) & (k units) Table 149. North America Heparin Sodium Injection Sales Market Share by Country (2021-2026) Table 150. North America Heparin Sodium Injection Sales Forecast by Country (2027-2032) & (k units) Table 151. North America Heparin Sodium Injection Sales Market Share Forecast by Country (2027-2032) Table 152. North America Heparin Sodium Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 153. North America Heparin Sodium Injection Market Size by Country (2021-2026) & (US$ Million) Table 154. North America Heparin Sodium Injection Market Share by Country (2021-2026) Table 155. North America Heparin Sodium Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 156. North America Heparin Sodium Injection Market Share Forecast by Country (2027-2032) Table 157. Europe Heparin Sodium Injection Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 158. Europe Heparin Sodium Injection Sales by Country (2021-2026) & (k units) Table 159. Europe Heparin Sodium Injection Sales Market Share by Country (2021-2026) Table 160. Europe Heparin Sodium Injection Sales Forecast by Country (2027-2032) & (k units) Table 161. Europe Heparin Sodium Injection Sales Market Share Forecast by Country (2027-2032) Table 162. Europe Heparin Sodium Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 163. Europe Heparin Sodium Injection Market Size by Country (2021-2026) & (US$ Million) Table 164. Europe Heparin Sodium Injection Market Share by Country (2021-2026) Table 165. Europe Heparin Sodium Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 166. Europe Heparin Sodium Injection Market Share Forecast by Country (2027-2032) Table 167. Asia-Pacific Heparin Sodium Injection Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 168. Asia-Pacific Heparin Sodium Injection Sales by Country (2021-2026) & (k units) Table 169. Asia-Pacific Heparin Sodium Injection Sales Market Share by Country (2021-2026) Table 170. Asia-Pacific Heparin Sodium Injection Sales Forecast by Country (2027-2032) & (k units) Table 171. Asia-Pacific Heparin Sodium Injection Sales Market Share Forecast by Country (2027-2032) Table 172. Asia-Pacific Heparin Sodium Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 173. Asia-Pacific Heparin Sodium Injection Market Size by Country (2021-2026) & (US$ Million) Table 174. Asia-Pacific Heparin Sodium Injection Market Share by Country (2021-2026) Table 175. Asia-Pacific Heparin Sodium Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 176. Asia-Pacific Heparin Sodium Injection Market Share Forecast by Country (2027-2032) Table 177. Latin America Heparin Sodium Injection Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 178. Latin America Heparin Sodium Injection Sales by Country (2021-2026) & (k units) Table 179. Latin America Heparin Sodium Injection Sales Market Share by Country (2021-2026) Table 180. Latin America Heparin Sodium Injection Sales Forecast by Country (2027-2032) & (k units) Table 181. Latin America Heparin Sodium Injection Sales Market Share Forecast by Country (2027-2032) Table 182. Latin America Heparin Sodium Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 183. Latin America Heparin Sodium Injection Market Size by Country (2021-2026) & (US$ Million) Table 184. Latin America Heparin Sodium Injection Market Share by Country (2021-2026) Table 185. Latin America Heparin Sodium Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 186. Latin America Heparin Sodium Injection Market Share Forecast by Country (2027-2032) Table 187. Middle East and Africa Heparin Sodium Injection Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 188. Middle East and Africa Heparin Sodium Injection Sales by Country (2021-2026) & (k units) Table 189. Middle East and Africa Heparin Sodium Injection Sales Market Share by Country (2021-2026) Table 190. Middle East and Africa Heparin Sodium Injection Sales Forecast by Country (2027-2032) & (k units) Table 191. Middle East and Africa Heparin Sodium Injection Sales Market Share Forecast by Country (2027-2032) Table 192. Middle East and Africa Heparin Sodium Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 193. Middle East and Africa Heparin Sodium Injection Market Size by Country (2021-2026) & (US$ Million) Table 194. Middle East and Africa Heparin Sodium Injection Market Share by Country (2021-2026) Table 195. Middle East and Africa Heparin Sodium Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 196. Middle East and Africa Heparin Sodium Injection Market Share Forecast by Country (2027-2032) Table 197. Key Raw Materials Table 198. Raw Materials Key Suppliers Table 199. Heparin Sodium Injection Distributors List Table 200. Heparin Sodium Injection Customers List Table 201. Research Programs/Design for This Report Table 202. Authors List of This Report Table 203. Secondary Sources Table 204. Primary Sources List of Figures Figure 1. Heparin Sodium Injection Image Figure 2. Global Heparin Sodium Injection Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Heparin Sodium Injection Market Size (2021-2032) & (US$ Million) Figure 4. Global Heparin Sodium Injection Sales (2021-2032) & (k units) Figure 5. 1, 000 USP Units / mL Image Figure 6. Global 1, 000 USP Units / mL Sales YoY Growth (2021-2032) & (k units) Figure 7. 5, 000 USP Units / mL Image Figure 8. Global 5, 000 USP Units / mL Sales YoY Growth (2021-2032) & (k units) Figure 9. 10, 000 USP Units / mL Image Figure 10. Global 10, 000 USP Units / mL Sales YoY Growth (2021-2032) & (k units) Figure 11. Global Heparin Sodium Injection Market Size Overview by Type (2021-2032) & (US$ Million) Figure 12. Global Heparin Sodium Injection Market Share by Type 2025 VS 2032 Figure 13. North America Heparin Sodium Injection Sales Market Share in Volume by Type in 2025 Figure 14. North America Heparin Sodium Injection Sales Market Share in Value by Type in 2025 Figure 15. Europe Heparin Sodium Injection Sales Market Share in Volume by Type in 2025 Figure 16. Europe Heparin Sodium Injection Sales Market Share in Value by Type in 2025 Figure 17. Asia-Pacific Heparin Sodium Injection Sales Market Share in Volume by Type in 2025 Figure 18. Asia-Pacific Heparin Sodium Injection Sales Market Share in Value by Type in 2025 Figure 19. Latin America Heparin Sodium Injection Sales Market Share in Volume by Type in 2025 Figure 20. Latin America Heparin Sodium Injection Sales Market Share in Value by Type in 2025 Figure 21. Middle East and Africa Heparin Sodium Injection Sales Market Share in Volume by Type in 2025 Figure 22. Middle East and Africa Heparin Sodium Injection Sales Market Share in Value by Type in 2025 Figure 23. Global Top 5 and 10 Heparin Sodium Injection Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. Cardioversion of Atrial Fibrillation/Flutter Image Figure 26. Global Cardioversion of Atrial Fibrillation/Flutter Sales YoY Growth (2021-2032) & (k units) Figure 27. Complications of Pregnancy Image Figure 28. Global Complications of Pregnancy Sales YoY Growth (2021-2032) & (k units) Figure 29. Treatment of Venous Thromboembolism Image Figure 30. Global Treatment of Venous Thromboembolism Sales YoY Growth (2021-2032) & (k units) Figure 31. Other Image Figure 32. Global Other Sales YoY Growth (2021-2032) & (k units) Figure 33. Global Heparin Sodium Injection Market Size Overview by Application (2021-2032) & (US$ Million) Figure 34. Global Heparin Sodium Injection Market Share by Application 2025 VS 2032 Figure 35. North America Heparin Sodium Injection Sales Market Share in Volume by Application in 2025 Figure 36. North America Heparin Sodium Injection Sales Market Share in Value by Application in 2025 Figure 37. Europe Heparin Sodium Injection Sales Market Share in Volume by Application in 2025 Figure 38. Europe Heparin Sodium Injection Sales Market Share in Value by Application in 2025 Figure 39. Asia-Pacific Heparin Sodium Injection Sales Market Share in Volume by Application in 2025 Figure 40. Asia-Pacific Heparin Sodium Injection Sales Market Share in Value by Application in 2025 Figure 41. Latin America Heparin Sodium Injection Sales Market Share in Volume by Application in 2025 Figure 42. Latin America Heparin Sodium Injection Sales Market Share in Value by Application in 2025 Figure 43. Middle East and Africa Heparin Sodium Injection Sales Market Share in Volume by Application in 2025 Figure 44. Middle East and Africa Heparin Sodium Injection Sales Market Share in Value by Application in 2025 Figure 45. North America Heparin Sodium Injection Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 46. North America Heparin Sodium Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. North America Heparin Sodium Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. North America Heparin Sodium Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Heparin Sodium Injection Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 50. Europe Heparin Sodium Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Heparin Sodium Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Europe Heparin Sodium Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Heparin Sodium Injection Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 54. Asia-Pacific Heparin Sodium Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific Heparin Sodium Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Asia-Pacific Heparin Sodium Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Heparin Sodium Injection Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 58. Latin America Heparin Sodium Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Heparin Sodium Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Latin America Heparin Sodium Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Heparin Sodium Injection Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 62. Middle East and Africa Heparin Sodium Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa Heparin Sodium Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 64. Middle East and Africa Heparin Sodium Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 65. Heparin Sodium Injection Value Chain Figure 66. Key Raw Materials Price Figure 67. Manufacturing Cost Structure Figure 68. Heparin Sodium Injection Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • 1, 000 USP Units / mL
  • 5, 000 USP Units / mL
  • 10, 000 USP Units / mL
Applications
  • Cardioversion of Atrial Fibrillation/Flutter
  • Complications of Pregnancy
  • Treatment of Venous Thromboembolism
  • Other
Companies covered
  • Sichuan Deebio
  • Shenzhen Hepalink
  • Nanjing King-friend
  • Pfizer
  • Changzhou Qianhong Bio-pharma
  • Baxter
  • Yino Pharma Limited
  • Xinbai Pharmaceuticals
  • Pharma Action
  • Opocrin
  • Dongying Tiandong Pharmaceutical
  • Dongcheng Biochemicals
  • Changshan Biochemical
  • Bioibérica
  • Aspen Oss

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Heparin Sodium Injection Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Heparin Sodium Injection Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Heparin Sodium Injection Market by Type
  6. 1.3.1 1, 000 USP Units / mL
  7. 1.3.2 5, 000 USP Units / mL
  8. 1.3.3 10, 000 USP Units / mL
  9. 1.4 Global Heparin Sodium Injection Market Size by Type
  10. 1.4.1 Global Heparin Sodium Injection Market Size Overview by Type (2021-2032)
  11. 1.4.2 Global Heparin Sodium Injection Historic Market Size Review by Type (2021-2026)
  12. 1.4.3 Global Heparin Sodium Injection Forecasted Market Size by Type (2027-2032)
  13. 1.5 Key Regions Market Size by Type
  14. 1.5.1 North America Heparin Sodium Injection Sales Breakdown by Type (2021-2026)
  15. 1.5.2 Europe Heparin Sodium Injection Sales Breakdown by Type (2021-2026)
  16. 1.5.3 Asia-Pacific Heparin Sodium Injection Sales Breakdown by Type (2021-2026)
  17. 1.5.4 South America Heparin Sodium Injection Sales Breakdown by Type (2021-2026)
  18. 1.5.5 Middle East and Africa Heparin Sodium Injection Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Heparin Sodium Injection Industry Trends
  2. 2.2 Heparin Sodium Injection Industry Drivers
  3. 2.3 Heparin Sodium Injection Industry Opportunities and Challenges
  4. 2.4 Heparin Sodium Injection Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Heparin Sodium Injection Revenue (2021-2026)
  2. 3.2 Global Top Players by Heparin Sodium Injection Sales (2021-2026)
  3. 3.3 Global Top Players by Heparin Sodium Injection Price (2021-2026)
  4. 3.4 Global Heparin Sodium Injection Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Heparin Sodium Injection Major Company Production Sites & Headquarters
  6. 3.6 Global Heparin Sodium Injection Company, Product Type & Application
  7. 3.7 Global Heparin Sodium Injection Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Heparin Sodium Injection Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Heparin Sodium Injection Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Heparin Sodium Injection Tier 1, Tier 2, and Tier 3
4 Heparin Sodium Injection Regional Status and Outlook
  1. 4.1 Global Heparin Sodium Injection Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Heparin Sodium Injection Historic Market Size by Region
  3. 4.2.1 Global Heparin Sodium Injection Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Heparin Sodium Injection Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Heparin Sodium Injection Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Heparin Sodium Injection Forecasted Market Size by Region
  7. 4.3.1 Global Heparin Sodium Injection Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Heparin Sodium Injection Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Heparin Sodium Injection Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Heparin Sodium Injection by Application
  1. 5.1 Heparin Sodium Injection Market by Application
  2. 5.1.1 Cardioversion of Atrial Fibrillation/Flutter
  3. 5.1.2 Complications of Pregnancy
  4. 5.1.3 Treatment of Venous Thromboembolism
  5. 5.1.4 Other
  6. 5.2 Global Heparin Sodium Injection Market Size by Application
  7. 5.2.1 Global Heparin Sodium Injection Market Size Overview by Application (2021-2032)
  8. 5.2.2 Global Heparin Sodium Injection Historic Market Size Review by Application (2021-2026)
  9. 5.2.3 Global Heparin Sodium Injection Forecasted Market Size by Application (2027-2032)
  10. 5.3 Key Regions Market Size by Application
  11. 5.3.1 North America Heparin Sodium Injection Sales Breakdown by Application (2021-2026)
  12. 5.3.2 Europe Heparin Sodium Injection Sales Breakdown by Application (2021-2026)
  13. 5.3.3 Asia-Pacific Heparin Sodium Injection Sales Breakdown by Application (2021-2026)
  14. 5.3.4 South America Heparin Sodium Injection Sales Breakdown by Application (2021-2026)
  15. 5.3.5 Middle East and Africa Heparin Sodium Injection Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Sichuan Deebio
  2. 6.1.1 Sichuan Deebio Company Information
  3. 6.1.2 Sichuan Deebio Business Overview
  4. 6.1.3 Sichuan Deebio Heparin Sodium Injection Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Sichuan Deebio Heparin Sodium Injection Product Portfolio
  6. 6.1.5 Sichuan Deebio Recent Developments
  7. 6.2 Shenzhen Hepalink
  8. 6.2.1 Shenzhen Hepalink Company Information
  9. 6.2.2 Shenzhen Hepalink Business Overview
  10. 6.2.3 Shenzhen Hepalink Heparin Sodium Injection Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Shenzhen Hepalink Heparin Sodium Injection Product Portfolio
  12. 6.2.5 Shenzhen Hepalink Recent Developments
  13. 6.3 Nanjing King-friend
  14. 6.3.1 Nanjing King-friend Company Information
  15. 6.3.2 Nanjing King-friend Business Overview
  16. 6.3.3 Nanjing King-friend Heparin Sodium Injection Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Nanjing King-friend Heparin Sodium Injection Product Portfolio
  18. 6.3.5 Nanjing King-friend Recent Developments
  19. 6.4 Pfizer
  20. 6.4.1 Pfizer Company Information
  21. 6.4.2 Pfizer Business Overview
  22. 6.4.3 Pfizer Heparin Sodium Injection Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Pfizer Heparin Sodium Injection Product Portfolio
  24. 6.4.5 Pfizer Recent Developments
  25. 6.5 Changzhou Qianhong Bio-pharma
  26. 6.5.1 Changzhou Qianhong Bio-pharma Company Information
  27. 6.5.2 Changzhou Qianhong Bio-pharma Business Overview
  28. 6.5.3 Changzhou Qianhong Bio-pharma Heparin Sodium Injection Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Changzhou Qianhong Bio-pharma Heparin Sodium Injection Product Portfolio
  30. 6.5.5 Changzhou Qianhong Bio-pharma Recent Developments
  31. 6.6 Baxter
  32. 6.6.1 Baxter Company Information
  33. 6.6.2 Baxter Business Overview
  34. 6.6.3 Baxter Heparin Sodium Injection Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Baxter Heparin Sodium Injection Product Portfolio
  36. 6.6.5 Baxter Recent Developments
  37. 6.7 Yino Pharma Limited
  38. 6.7.1 Yino Pharma Limited Company Information
  39. 6.7.2 Yino Pharma Limited Business Overview
  40. 6.7.3 Yino Pharma Limited Heparin Sodium Injection Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Yino Pharma Limited Heparin Sodium Injection Product Portfolio
  42. 6.7.5 Yino Pharma Limited Recent Developments
  43. 6.8 Xinbai Pharmaceuticals
  44. 6.8.1 Xinbai Pharmaceuticals Company Information
  45. 6.8.2 Xinbai Pharmaceuticals Business Overview
  46. 6.8.3 Xinbai Pharmaceuticals Heparin Sodium Injection Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Xinbai Pharmaceuticals Heparin Sodium Injection Product Portfolio
  48. 6.8.5 Xinbai Pharmaceuticals Recent Developments
  49. 6.9 Pharma Action
  50. 6.9.1 Pharma Action Company Information
  51. 6.9.2 Pharma Action Business Overview
  52. 6.9.3 Pharma Action Heparin Sodium Injection Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Pharma Action Heparin Sodium Injection Product Portfolio
  54. 6.9.5 Pharma Action Recent Developments
  55. 6.10 Opocrin
  56. 6.10.1 Opocrin Company Information
  57. 6.10.2 Opocrin Business Overview
  58. 6.10.3 Opocrin Heparin Sodium Injection Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Opocrin Heparin Sodium Injection Product Portfolio
  60. 6.10.5 Opocrin Recent Developments
  61. 6.11 Dongying Tiandong Pharmaceutical
  62. 6.11.1 Dongying Tiandong Pharmaceutical Company Information
  63. 6.11.2 Dongying Tiandong Pharmaceutical Business Overview
  64. 6.11.3 Dongying Tiandong Pharmaceutical Heparin Sodium Injection Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Dongying Tiandong Pharmaceutical Heparin Sodium Injection Product Portfolio
  66. 6.11.5 Dongying Tiandong Pharmaceutical Recent Developments
  67. 6.12 Dongcheng Biochemicals
  68. 6.12.1 Dongcheng Biochemicals Company Information
  69. 6.12.2 Dongcheng Biochemicals Business Overview
  70. 6.12.3 Dongcheng Biochemicals Heparin Sodium Injection Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Dongcheng Biochemicals Heparin Sodium Injection Product Portfolio
  72. 6.12.5 Dongcheng Biochemicals Recent Developments
  73. 6.13 Changshan Biochemical
  74. 6.13.1 Changshan Biochemical Company Information
  75. 6.13.2 Changshan Biochemical Business Overview
  76. 6.13.3 Changshan Biochemical Heparin Sodium Injection Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Changshan Biochemical Heparin Sodium Injection Product Portfolio
  78. 6.13.5 Changshan Biochemical Recent Developments
  79. 6.14 Bioibérica
  80. 6.14.1 Bioibérica Company Information
  81. 6.14.2 Bioibérica Business Overview
  82. 6.14.3 Bioibérica Heparin Sodium Injection Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 Bioibérica Heparin Sodium Injection Product Portfolio
  84. 6.14.5 Bioibérica Recent Developments
  85. 6.15 Aspen Oss
  86. 6.15.1 Aspen Oss Company Information
  87. 6.15.2 Aspen Oss Business Overview
  88. 6.15.3 Aspen Oss Heparin Sodium Injection Sales, Revenue and Gross Margin (2021-2026)
  89. 6.15.4 Aspen Oss Heparin Sodium Injection Product Portfolio
  90. 6.15.5 Aspen Oss Recent Developments
7 North America by Country
  1. 7.1 North America Heparin Sodium Injection Sales by Country
  2. 7.1.1 North America Heparin Sodium Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Heparin Sodium Injection Sales by Country (2021-2026)
  4. 7.1.3 North America Heparin Sodium Injection Sales Forecast by Country (2027-2032)
  5. 7.2 North America Heparin Sodium Injection Market Size by Country
  6. 7.2.1 North America Heparin Sodium Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Heparin Sodium Injection Market Size by Country (2021-2026)
  8. 7.2.3 North America Heparin Sodium Injection Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Heparin Sodium Injection Sales by Country
  2. 8.1.1 Europe Heparin Sodium Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Heparin Sodium Injection Sales by Country (2021-2026)
  4. 8.1.3 Europe Heparin Sodium Injection Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Heparin Sodium Injection Market Size by Country
  6. 8.2.1 Europe Heparin Sodium Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Heparin Sodium Injection Market Size by Country (2021-2026)
  8. 8.2.3 Europe Heparin Sodium Injection Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Heparin Sodium Injection Sales by Country
  2. 9.1.1 Asia-Pacific Heparin Sodium Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Heparin Sodium Injection Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Heparin Sodium Injection Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Heparin Sodium Injection Market Size by Country
  6. 9.2.1 Asia-Pacific Heparin Sodium Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Heparin Sodium Injection Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Heparin Sodium Injection Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Heparin Sodium Injection Sales by Country
  2. 10.1.1 South America Heparin Sodium Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Heparin Sodium Injection Sales by Country (2021-2026)
  4. 10.1.3 South America Heparin Sodium Injection Sales Forecast by Country (2027-2032)
  5. 10.2 South America Heparin Sodium Injection Market Size by Country
  6. 10.2.1 South America Heparin Sodium Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Heparin Sodium Injection Market Size by Country (2021-2026)
  8. 10.2.3 South America Heparin Sodium Injection Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Heparin Sodium Injection Sales by Country
  2. 11.1.1 Middle East and Africa Heparin Sodium Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Heparin Sodium Injection Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Heparin Sodium Injection Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Heparin Sodium Injection Market Size by Country
  6. 11.2.1 Middle East and Africa Heparin Sodium Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Heparin Sodium Injection Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Heparin Sodium Injection Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Heparin Sodium Injection Value Chain Analysis
  2. 12.1.1 Heparin Sodium Injection Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Heparin Sodium Injection Production Mode & Process
  7. 12.2 Heparin Sodium Injection Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Heparin Sodium Injection Distributors
  10. 12.2.3 Heparin Sodium Injection Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst